(Q104103130)

1,2,4,5,6-Pentahydroxyhexan-3-yl 5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoate

1 reference

2,3,4,5,6-Pentahydroxyhexyl 5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoate

1 reference

2,3,4,5-Tetrahydroxypentyl 13-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethylicosa-2,6,10,14-tetraenoate

1 reference

1 reference

1 reference

[(2R,3R,4R,5R)-1,2,4,5,6-pentahydroxyhexan-3-yl] (2E,4S,5S,6E,8S,9S,10E,12S,13S,14E,16S,18S)-5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoate

1 reference

[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl] (2E,4S,5S,6E,8S,9S,10E,12S,13S,14E,16S,18S)-13-[(2S,3S,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethylicosa-2,6,10,14-tetraenoate

1 reference

[(2R,3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-yl] (2E,4S,5S,6E,8S,9S,10E,12S,13S,14E,16S,18S)-5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoate

1 reference

[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] (2E,4S,5S,6E,8S,9S,10E,12S,13S,14E,16S,18S)-5,9-dihydroxy-2,4,6,8,10,12,14,16,18-nonamethyl-13-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosa-2,6,10,14-tetraenoate

1 reference

Jun Kohno

1

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Maki Nishio

2

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Masaaki Sakurai

3

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Kimio Kawano

4

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Hajime Hiramatsu

5

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Noriaki Kameda

6

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Noboru Kishi

7

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Toyoharu Yamashita

8

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Toru Okuda

9

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

Saburo Komatsubara

10

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

publication date

June 1999

1 reference

16 September 2022

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

volume

55

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

issue

25

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

page(s)

7771-7786

1 reference

http://api.crossref.org/works/10.1016%2Fs0040-4020%2899%2900408-1

cites work

Anthrotainin, an inhibitor of substance P binding produced by Gliocladium catenulatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Inhibition of c-fos proto-oncogene induction by Sch 52900 and Sch 52901, novel diketopiperazine produced by Gliocladium sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Studies on metabolites of mycoparasitic fungi. II. Metabolites of Trichoderma koningii

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

A new sesquiterpene antibiotic, heptelidic acid producing organisms, fermentation, isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Glisoprenins, new inhibitors of acyl-CoA: Cholesterol acyltransferase produced by Gliocladium sp. FO-1513. I. Production, isolation and physico-chemical and biological properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. II. Structure elucidation of glisoprenins A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

THE STRUCTURE AND STEREOCHEMISTRY OF ERYTHROMYCIN A

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Antibiotic glycosides. 8. Erythromycin D, a new macrolide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

Megalomicins. II. Structure of megalomicin A

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021

MACROLIDE STEREOCHEMISTRY. I. THE TOTAL ABSOLUTE CONFIGURATION OF OLEANDOMYCIN

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2899%2900408-1

7 January 2021